Insider · CIK 0001730336

Bruno Lawrence

Reports to the SEC for 2 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001730336

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-31	CLBCore Laboratories Inc. /DE/P Purchase	Director, Chairman and CEO	PPurchase	+5,000 sh	$10.78	+$53.9K	262,438
2026-02-12	CLBCore Laboratories Inc. /DE/ · Performance SharesA Award	Director, Chairman and CEO	AAward	+204K sh	—	—	204,340
2025-12-31	CLBCore Laboratories Inc. /DE/F Tax Payment	Director, Chairman and CEO	FTax Payment	−113K sh	$16.03	−$1.81M	257,438
2025-12-31	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+181K sh	—	—	370,119
2025-12-31	CLBCore Laboratories Inc. /DE/ · Performance SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−181K sh	—	—	0
2025-02-13	CLBCore Laboratories Inc. /DE/ · Performance SharesA Award	Director, Chairman and CEO	AAward	+203K sh	—	—	202,764
2024-12-31	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+69.6K sh	—	—	232,777
2024-12-31	CLBCore Laboratories Inc. /DE/F Tax Payment	Director, Chairman and CEO	FTax Payment	−43.4K sh	$17.31	−$751K	189,397
2024-12-31	CLBCore Laboratories Inc. /DE/ · Performance SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−69.6K sh	—	—	0
2024-02-15	CLBCore Laboratories Inc. /DE/ · Performance SharesA Award	Director, Chairman and CEO	AAward	+234K sh	—	—	234,124
2023-12-31	CLBCore Laboratories Inc. /DE/ · Performance SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−100K sh	—	—	0
2023-12-31	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+100K sh	—	—	202,576
2023-12-31	CLBCore Laboratories Inc. /DE/F Tax Payment	Director, Chairman and CEO	FTax Payment	−39.4K sh	$17.66	−$695K	163,203
2023-12-31	CLBCore Laboratories Inc. /DE/F Tax Payment	Director, Chairman and CEO	FTax Payment	−38.5K sh	$17.66	−$679K	164,103
2023-02-16	CORE LABORATORIES N VPerformance SharesA Award	Director, Chairman and CEO	AAward	+155K sh	—	—	155,126
2022-12-31	CORE LABORATORIES N VPerformance SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−91.2K sh	—	—	0
2022-12-31	CORE LABORATORIES N VM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+91.2K sh	—	—	138,410
2022-12-31	CORE LABORATORIES N VF Tax Payment	Director, Chairman and CEO	FTax Payment	−35.9K sh	$20.27	−$728K	102,518
2022-02-17	CORE LABORATORIES N VPerformance SharesA Award	Director, Chairman and CEO	AAward	+127K sh	—	—	127,424
2021-12-31	CORE LABORATORIES N VPerformance SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−46.2K sh	—	—	0
2021-12-31	CORE LABORATORIES N VF Tax Payment	Director, Chairman and CEO	FTax Payment	−18.2K sh	$22.31	−$406K	47,198
2021-12-31	CORE LABORATORIES N VM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+46.2K sh	—	—	65,391
2021-02-19	CORE LABORATORIES N VPerformance SharesA Award	Director, Chairman and CEO	AAward	+94.2K sh	—	—	94,172
2020-12-31	CORE LABORATORIES N VM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+13.7K sh	—	—	24,542
2020-12-31	CORE LABORATORIES N VF Tax Payment	Director, Chairman and CEO	FTax Payment	−5,384 sh	$26.51	−$143K	19,158
2020-12-31	CORE LABORATORIES N VPerformance SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−13.7K sh	—	—	0
2020-04-01	CORE LABORATORIES N VRestricted SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−100 sh	—	—	0
2020-04-01	CORE LABORATORIES N VM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+100 sh	—	—	10,899
2020-04-01	CORE LABORATORIES N VF Tax Payment	Director, Chairman and CEO	FTax Payment	−39 sh	$9.49	−$370.11	10,860
2020-02-11	CORE LABORATORIES N VPerformance SharesA Award	Director, Chairman and CEO	AAward	+91.2K sh	—	—	91,212
2020-02-03	CORE LABORATORIES N VP Purchase	Director, Chairman and CEO	PPurchase	+1,000 sh	$35.00	+$35K	8,799
2020-02-03	CORE LABORATORIES N VP Purchase	Director, Chairman and CEO	PPurchase	+1,000 sh	$34.98	+$35K	9,799
2020-02-03	CORE LABORATORIES N VP Purchase	Director, Chairman and CEO	PPurchase	+1,000 sh	$34.60	+$34.6K	10,799
2019-12-31	CORE LABORATORIES N VF Tax Payment	Director, Chairman and CEO	FTax Payment	−945 sh	$37.67	−$35.6K	7,799
2019-12-31	CORE LABORATORIES N VPerformance SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−2,400 sh	—	—	0
2019-12-31	CORE LABORATORIES N VM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+2,400 sh	—	—	8,744
2019-04-01	CORE LABORATORIES N VF Tax Payment	Director, Chairman and CEO	FTax Payment	−46 sh	$68.93	−$3,170.78	6,344
2019-04-01	CORE LABORATORIES N VA Award	Director, Chairman and CEO	AAward	−100 sh	—	—	6,290
2019-04-01	CORE LABORATORIES N VM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+100 sh	—	—	6,390
2019-04-01	CORE LABORATORIES N VRestricted SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−100 sh	—	—	100
2019-02-12	CORE LABORATORIES N VPerformance SharesA Award	Director, Chairman and CEO	AAward	+30.8K sh	—	—	30,822
2018-12-31	CORE LABORATORIES N VM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+3,000 sh	—	—	7,571
2018-12-31	CORE LABORATORIES N VPerformance SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−3,000 sh	—	—	0
2018-12-31	CORE LABORATORIES N VF Tax Payment	Director, Chairman and CEO	FTax Payment	−1,181 sh	$59.66	−$70.5K	6,390
2018-09-01	CORE LABORATORIES N VM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+100 sh	—	—	4,610
2018-09-01	CORE LABORATORIES N VRestricted SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−100 sh	—	—	200
2018-09-01	CORE LABORATORIES N VF Tax Payment	Director, Chairman and CEO	FTax Payment	−39 sh	$114.55	−$4,467.45	4,571
2018-08-01	CORE LABORATORIES N VRestricted SharesM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−200 sh	—	—	300
2018-08-01	CORE LABORATORIES N VM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+200 sh	—	—	4,557
2018-08-01	CORE LABORATORIES N VF Tax Payment	Director, Chairman and CEO	FTax Payment	−47 sh	$111.91	−$5,259.77	4,510

Recent filings

Accepted (ET)
Aug 44
Bruno Lawrence0001193125-26-331852
SEC(opens sec.gov)
Feb 174
Bruno Lawrence0001193125-26-053588
SEC(opens sec.gov)
Jan 54
Bruno Lawrence0001193125-26-002248
SEC(opens sec.gov)
Feb 134
Bruno Lawrence0000950170-25-019957
SEC(opens sec.gov)
Jan 34
Bruno Lawrence0000950170-25-001332
SEC(opens sec.gov)
Feb 154
Bruno Lawrence0000950170-24-015891
SEC(opens sec.gov)
Jan 84/A
Bruno Lawrence0000950170-24-002882
SEC(opens sec.gov)
Jan 34
Bruno Lawrence0000950170-24-001227
SEC(opens sec.gov)
Feb 214
Bruno Lawrence0001209191-23-011093
SEC(opens sec.gov)
Jan 44
Bruno Lawrence0001209191-23-001001
SEC(opens sec.gov)
Feb 174
Bruno Lawrence0001209191-22-010858
SEC(opens sec.gov)
Jan 44
Bruno Lawrence0001209191-22-001059
SEC(opens sec.gov)

Companies

Address

6316 WINDFERN ROAD

HOUSTON, TX, 77040